VIGIL HEMOGLOBIN (HBALC) CONTROLS— 510(k) K982022

Substantially Equivalent

Beckman Coulter, Inc.

FDA 510(k) clearance K982022 for VIGIL HEMOGLOBIN (HBALC) CONTROLS, Substantially Equivalent on 1998-07-06. Applicant: Beckman Coulter, Inc..

Clearance details

Applicant: Beckman Coulter, Inc.
Product code: Code JJX
Advisory panel: Clinical Chemistry
Date received: 1998-06-09
Decision date: 1998-07-06
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Brea, CA, US

Download summary PDF View on FDA.gov ↗

Adverse events under product code JJX

product code JJX

Other: 2
Total: 2

Source: openFDA MAUDE database, 2020-01-01 through 2026-04-23. Counts aggregate all devices under this product code, not just this specific clearance. Reports are submissions to FDA, not validated events. Search MAUDE directly →

Data sourced from openFDA. This site is unofficial and independent of the FDA.